HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

François Ghiringhelli Selected Research

Calreticulin

1/2013Bleomycin exerts ambivalent antitumor immune effect by triggering both immunogenic cell death and proliferation of regulatory T cells.
9/2012An immunosurveillance mechanism controls cancer cell ploidy.
9/2009Witch hunt against tumor cells enhanced by dendritic cells.
12/2007Ecto-calreticulin in immunogenic chemotherapy.
10/2007Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference.
9/2007Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from "silent" to immunogenic.
3/2007Immunogenic chemotherapy: discovery of a critical protein through proteomic analyses of tumor cells.
3/2007[Calreticulin dictates the immunogenicity of anti-cancer chemotherapy and radiotherapy].
1/2007Calreticulin exposure dictates the immunogenicity of cancer cell death.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


François Ghiringhelli Research Topics

Disease

71Neoplasms (Cancer)
10/2015 - 12/2003
10Breast Neoplasms (Breast Cancer)
10/2015 - 09/2007
8Colonic Neoplasms (Colon Cancer)
09/2015 - 04/2004
6Colorectal Neoplasms (Colorectal Cancer)
06/2015 - 03/2010
4Melanoma (Melanoma, Malignant)
01/2014 - 04/2006
4Carcinoma (Carcinomatosis)
09/2012 - 04/2008
3Neoplasm Metastasis (Metastasis)
10/2015 - 03/2010
2Adenocarcinoma
01/2015 - 09/2012
2Lymphopenia (Lymphocytopenia)
01/2014 - 10/2009
2Glioblastoma (Glioblastoma Multiforme)
08/2013 - 10/2009
2Hepatocellular Carcinoma (Hepatoma)
07/2012 - 06/2009
2Glioma (Gliomas)
04/2012 - 10/2009
2Infection
02/2012 - 01/2011
2Ovarian Neoplasms (Ovarian Cancer)
12/2011 - 01/2011
2Polyploidy
06/2009 - 09/2008
2Residual Neoplasm
06/2008 - 10/2007
1Fibrosis (Cirrhosis)
12/2015
1Inflammation
08/2015
1Chromosomal Instability (Chromosome Stability)
04/2015
1Pancreatic Neoplasms (Pancreatic Cancer)
06/2014
1Obesity
02/2014
1Cholangiocarcinoma
12/2013
1Hodgkin Disease (Hodgkin's Disease)
01/2013
1Testicular Neoplasms (Testicular Cancer)
01/2013
1Neutropenia
01/2013
1Thrombocytopenia (Thrombopenia)
01/2013
1Hypersensitivity (Allergy)
01/2013
1Cadaver (Cadavers)
09/2012
1Acute Kidney Injury (Acute Renal Failure)
02/2012
1Critical Illness (Critically Ill)
02/2012

Drug/Important Bio-Agent (IBA)

9oxaliplatin (Eloxatin)FDA LinkGeneric
01/2014 - 02/2010
9CalreticulinIBA
01/2013 - 01/2007
8AntigensIBA
12/2014 - 02/2006
8Fluorouracil (Carac)FDA LinkGeneric
06/2014 - 04/2010
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2013 - 02/2004
6HMGB1 Protein (HMG1)IBA
10/2015 - 09/2007
5irinotecan (Camptosar)FDA LinkGeneric
06/2015 - 04/2012
5DNA (Deoxyribonucleic Acid)IBA
04/2015 - 01/2007
5AnthracyclinesIBA
07/2012 - 09/2007
5Adenosine Triphosphate (ATP)IBA
01/2012 - 04/2004
4InterferonsIBA
03/2014 - 02/2006
4bevacizumabFDA Link
01/2014 - 03/2010
4Transforming Growth Factor beta (TGF-beta)IBA
01/2013 - 02/2004
4Cisplatin (Platino)FDA LinkGeneric
12/2011 - 04/2006
4Neoplasm Antigens (Tumor Antigens)IBA
11/2008 - 02/2006
4Toll-Like Receptor 4IBA
10/2008 - 09/2007
3LigandsIBA
09/2015 - 09/2008
3Biological Markers (Surrogate Marker)IBA
03/2015 - 08/2008
3CytokinesIBA
02/2015 - 06/2012
3resveratrolIBA
07/2013 - 01/2011
3gemcitabineFDA Link
09/2012 - 03/2010
3Interferon-gamma (Interferon, gamma)IBA
02/2010 - 09/2008
2Cathepsin BIBA
06/2014 - 01/2013
2Interleukin-17 (Interleukin 27)IBA
06/2014 - 03/2011
2trastuzumab (Herceptin)FDA Link
03/2014 - 01/2011
2AdenosineFDA LinkGeneric
03/2014 - 01/2012
2Dacarbazine (DIC)FDA LinkGeneric
01/2014 - 02/2013
2Leucovorin (Folinic Acid)FDA Link
01/2014 - 09/2012
2temozolomide (Temodar)FDA LinkGeneric
08/2013 - 10/2009
2phytoalexinsIBA
07/2013 - 01/2011
2Reactive Oxygen Species (Oxygen Radicals)IBA
04/2013 - 04/2004
2Interleukin-1 (Interleukin 1)IBA
01/2013 - 10/2009
2InterleukinsIBA
06/2012 - 03/2011
1Immunoglobulin G (IgG)IBA
12/2015
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
10/2015
1liver X receptorIBA
09/2015
1Interleukin-13IBA
08/2015
1Interleukin-5 (Interleukin 5)IBA
08/2015
1Interleukin-4 (Interleukin 4)IBA
08/2015
1Angiopoietin-2IBA
03/2015
1Interleukin-9 (Interleukin 9)IBA
02/2015
1interleukin-21 (interleukin 21)IBA
02/2015
1taxaneIBA
01/2015
1Monoclonal AntibodiesIBA
12/2014
1O-cyclopentyl-S-diethylaminoethyl methylphosphonothioateIBA
03/2014
1TaxoidsIBA
02/2014
1Immunologic Factors (Immunomodulators)IBA
01/2014
1Intrahepatic cholangiocarcinomaIBA
12/2013
1Anti-Bacterial Agents (Antibiotics)IBA
11/2013
1Linoleic Acid (Linoleate)IBA
04/2013
1Messenger RNA (mRNA)IBA
04/2013
1trans-10,cis-12-conjugated linoleic acidIBA
04/2013
1OxygenIBA
01/2013
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2013
1Digoxin (Digitek)FDA LinkGeneric
07/2012
1Interleukin-18 (Interleukin 18)IBA
06/2012
1sodium citrateFDA LinkGeneric
02/2012
1Citric Acid (Citrate)FDA LinkGeneric
02/2012
1Carbon MonoxideIBA
01/2012
1EnzymesIBA
12/2011

Therapy/Procedure

44Drug Therapy (Chemotherapy)
10/2015 - 04/2004
14Radiotherapy
04/2015 - 03/2007
7Immunotherapy
12/2014 - 02/2004
3Adjuvant Chemotherapy
10/2015 - 08/2011
3Aftercare (After-Treatment)
06/2014 - 03/2011
1Tissue Therapy (Cell Therapy)
02/2015
1Catheters
02/2012
1Intensive Care (Surgical Intensive Care)
02/2012
1Renal Dialysis (Hemodialysis)
02/2012
1Therapeutics
01/2012